These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6392315)

  • 1. Effects of staphylococcal protein A-treated human leukemic serum on autologous leukemic blast growth and mitogenesis of lymphocytes.
    Spitzer TR; Lazarus HM
    J Clin Immunol; 1984 Nov; 4(6):455-60. PubMed ID: 6392315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro tumoricidal activity of immunoadsorbed leukemic serum.
    Miller WJ; Branda RF
    J Biol Response Mod; 1984; 3(3):231-4. PubMed ID: 6379106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis.
    Miller WJ; Branda RF; Hurd DD; Wachsman W; Nelson NL; Jacob HS
    Blood; 1982 Jun; 59(6):1344-7. PubMed ID: 7044448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
    van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
    Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.
    Lee SK; Oliver RT
    J Exp Med; 1978 Mar; 147(3):912-22. PubMed ID: 305461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
    Draube A; Beyer M; Wolf J
    Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.
    Sondel PM; O'Brien C; Porter L; Schlossman SF; Chess L
    J Immunol; 1976 Dec; 117(6):2197-203. PubMed ID: 1069027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thrombopoietin on acute myelogenous leukemia blasts.
    Tokunaga Y; Miyamoto T; Gondo H; Okamura T; Niho Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):27-37. PubMed ID: 10721767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
    Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
    J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interleukin-2 activates peripheral blood lymphocytes from children with acute leukemia to kill autologous leukemic cells.
    Findley HW; Abdel Mageed A; Nasr SA; Ragab AH
    Cancer; 1988 Nov; 62(9):1928-31. PubMed ID: 3262410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
    Cocks P; Powles RL; Chapuis B; Alexander P
    Br J Cancer; 1977 Mar; 35(3):273-9. PubMed ID: 139910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
    Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
    Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival.
    Lauria F; Raspadori D; Rondelli D; Ventura MA; Foà R
    Leukemia; 1994 May; 8(5):724-8. PubMed ID: 8182932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
    Liepert A; Grabrucker C; Kremser A; Dreyssig J; Ansprenger C; Freudenreich M; Kroell T; Reibke R; Tischer J; Schweiger C; Schmid C; Kolb HJ; Schmetzer H
    Cell Immunol; 2010; 265(1):23-30. PubMed ID: 20663492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
    Yang T; Chen ZZ; Kolb HJ; Buhmann R
    Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
    Taylor GM; Freeman CB; Harris R
    Br J Cancer; 1976 May; 33(5):501-11. PubMed ID: 1064430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell qualities of lymphocytes and/or leukemic cells from peripheral blood in acute myeloid and lymphatic leukemia before treatment and at relapse.
    de Vaan GA; Bakkeren JA; Schretlen ED
    Biomedicine; 1975 Nov; 22(6):524-31. PubMed ID: 1083749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
    Bruserud O; Ulvestad E
    J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.